Skip to main content

Daiwa Securities Group Inc.

Broker-Dealer

Position in NBIX — Neurocrine Biosciences Inc

CIK 1481045 CHIYODA-KU,TOKYO, M0

Position in NBIX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$2,962,173
+$562,835 QoQ
Shares Held
22,485
+32.9% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 84.61641094062709.ToString("F0")% Shared 15.383589059372916.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Daiwa Securities Group Inc. holds $24,604,001 across 9 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (12.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NBIX
Neurocrine Biosciences Inc
This page
22,485 $2,962,173

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,962,173 22,485
2025-12-31 $2,399,338 16,917
2025-09-30 $1,226,640 8,738
2025-06-30 $1,088,475 8,660
2025-03-31 $1,190,056 10,760
2024-12-31 $1,113,840 8,160
2024-09-30 $1,359,365 11,798
2024-06-30 $1,211,633 8,801
2024-03-31 $1,184,732 8,590
2023-12-31 $853,936 6,481
2023-09-30 $678,375 6,030
2023-06-30 $568,629 6,030
2023-03-31 $583,634 5,766
2022-12-31 $664,803 5,566
2022-09-30 $919,672 8,659
2022-06-30 $852,851 8,749
2022-03-31 $964,593 10,289
2021-12-31 $879,805 10,330
2021-09-30 $1,037,458 10,817
2021-06-30 $1,035,776 10,643
2021-03-31 $1,057,010 10,869
2020-12-31 $1,059,621 11,055
2020-09-30 $843,033 8,767
2020-06-30 $1,727,398 14,159
2020-03-31 $1,225,460 14,159